Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Noel

Showing results (641-650 of 787) with videos related to

Pageof 79
Sort By:
European Heart Journal|March 6, 2026
Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaquesDuk-Woo Park, William E Boden, Raffaele De Caterina, et al.
International Journal of Cardiology. Heart & Vasculature|April 1, 2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)Erika Jones, B Delia Johnson, Leslee J Shaw, et al.
Oncotarget|October 27, 2016
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanomaLorena P Suarez-Kelly, Gregory M Kemper, Megan C Duggan, et al.
Journal of the American Heart Association|June 25, 2020
Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVDOdayme Quesada, Melody Hermel, Nissi Suppogu, et al.
Journal of Behavioral Medicine|March 28, 2016
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationThomas Rutledge, Tanya S Kenkre, Diane V Thompson, et al.
International Journal of Cardiology|October 9, 2018
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary studyCecil A Rambarat, Islam Y Elgendy, Eileen M Handberg, et al.
Circulation|June 18, 2003
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery diseaseQi Chen, Steven E Reis, Candace Kammerer, et al.
American Heart Journal|August 9, 2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseOscar C Marroquin, Kevin E Kip, Suresh R Mulukutla, et al.
Cardiovascular Diagnosis and Therapy|October 18, 2016
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Mark Doyle, Gerald M Pohost, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) StudyEileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Pageof 79

Showing results (641-650 of 787) with videos related to

Sort By:
Pageof 79
European Heart Journal|March 6, 2026
Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaquesDuk-Woo Park, William E Boden, Raffaele De Caterina, et al.
International Journal of Cardiology. Heart & Vasculature|April 1, 2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)Erika Jones, B Delia Johnson, Leslee J Shaw, et al.
Oncotarget|October 27, 2016
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanomaLorena P Suarez-Kelly, Gregory M Kemper, Megan C Duggan, et al.
Journal of the American Heart Association|June 25, 2020
Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVDOdayme Quesada, Melody Hermel, Nissi Suppogu, et al.
Journal of Behavioral Medicine|March 28, 2016
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationThomas Rutledge, Tanya S Kenkre, Diane V Thompson, et al.
International Journal of Cardiology|October 9, 2018
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary studyCecil A Rambarat, Islam Y Elgendy, Eileen M Handberg, et al.
Circulation|June 18, 2003
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery diseaseQi Chen, Steven E Reis, Candace Kammerer, et al.
American Heart Journal|August 9, 2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseOscar C Marroquin, Kevin E Kip, Suresh R Mulukutla, et al.
Cardiovascular Diagnosis and Therapy|October 18, 2016
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Mark Doyle, Gerald M Pohost, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) StudyEileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Pageof 79